BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 27479501)

  • 1. Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.
    Deforche L; Tersteeg C; Roose E; Vandenbulcke A; Vandeputte N; Pareyn I; De Cock E; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    PLoS One; 2016; 11(8):e0160388. PubMed ID: 27479501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura.
    Tersteeg C; Schiviz A; De Meyer SF; Plaimauer B; Scheiflinger F; Rottensteiner H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2336-42. PubMed ID: 26338302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model.
    Ostertag EM; Bdeir K; Kacir S; Thiboutot M; Gulendran G; Yunk L; Hayes VM; Motto DG; Poncz M; Zheng XL; Cines DB; Siegel DL
    Transfusion; 2016 Jul; 56(7):1775-85. PubMed ID: 27040023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.
    BĂ©ranger N; Benghezal S; Savigny S; Capdenat S; Joly BS; Coppo P; Stepanian A; Veyradier A
    Thromb Res; 2019 Sep; 181():29-35. PubMed ID: 31330376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.
    Mancini I; Valsecchi C; Lotta LA; Deforche L; Pontiggia S; Bajetta M; Palla R; Vanhoorelbeke K; Peyvandi F
    Thromb Haemost; 2014 Aug; 112(2):297-303. PubMed ID: 24740645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13.
    Schiviz A; Wuersch K; Piskernik C; Dietrich B; Hoellriegl W; Rottensteiner H; Scheiflinger F; Schwarz HP; Muchitsch EM
    Blood; 2012 Jun; 119(25):6128-35. PubMed ID: 22529289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity.
    Kato S; Matsumoto M; Matsuyama T; Isonishi A; Hiura H; Fujimura Y
    Transfusion; 2006 Aug; 46(8):1444-52. PubMed ID: 16934083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement.
    Joly B; Stepanian A; Hajage D; Thouzeau S; Capdenat S; Coppo P; Veyradier A
    Thromb Res; 2014 Nov; 134(5):1074-80. PubMed ID: 25262108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons.
    Feys HB; Roodt J; Vandeputte N; Pareyn I; Mottl H; Hou S; Lamprecht S; Van Rensburg WJ; Deckmyn H; Vanhoorelbeke K
    Blood; 2012 Oct; 120(17):3611-4. PubMed ID: 22855603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies.
    Crawley JT; Scully MA
    Hematology Am Soc Hematol Educ Program; 2013; 2013():292-9. PubMed ID: 24319194
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Tersteeg C; Roodt J; Van Rensburg WJ; Dekimpe C; Vandeputte N; Pareyn I; Vandenbulcke A; Plaimauer B; Lamprecht S; Deckmyn H; Lopez JA; De Meyer SF; Vanhoorelbeke K
    Blood; 2017 Feb; 129(8):1030-1038. PubMed ID: 28011677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.
    Motto DG; Chauhan AK; Zhu G; Homeister J; Lamb CB; Desch KC; Zhang W; Tsai HM; Wagner DD; Ginsburg D
    J Clin Invest; 2005 Oct; 115(10):2752-61. PubMed ID: 16200209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic inactivation of ADAMTS13 by plasmin in human plasma: risk of thrombotic thrombocytopenic purpura.
    Shin Y; Miyake H; Togashi K; Hiratsuka R; Endou-Ohnishi K; Imamura Y
    J Biochem; 2018 May; 163(5):381-389. PubMed ID: 29228282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
    Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of vWF73 and VWF114 fragments of von Willebrand factor A2 domain and their utilization in detecting ADAMTS13 activity].
    Zhang JY; Ma ZN; Dong NZ; Hu LP; Su J; Wang ZY; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):337-41. PubMed ID: 21729605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.
    Pillai VG; Bao J; Zander CB; McDaniel JK; Chetty PS; Seeholzer SH; Bdeir K; Cines DB; Zheng XL
    Blood; 2016 Jul; 128(1):110-9. PubMed ID: 27207796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique case of autoantibody mediated inactivation of ADAMTS13 in an Indian TTP patient.
    Bhakuni T; Singhal R; Annarapu GK; Sharma A; Mahapatra M; Saxena R; Guchhait P
    Blood Cells Mol Dis; 2019 Jul; 77():29-33. PubMed ID: 30953939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.